Versigent Analyst Price Targets - Benzinga

Versigent PLC

VGNTNYSE

Trade with Public

Trade with Public

$43.65

0.210.48%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Versigent Analyst Price Targets - Benzinga

Versigent Analyst Price Targets

Wall Street analyst price targets and consensus rating for Versigent (VGNT).

Price Target Range — 3 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$56Upside to Avg. PT+28.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	RBC Capital	Tom Narayan	PT Raise	Outperform	$52→$53
Oct 6, 2026	Goldman Sachs	Mark Delaney	PT Cut	Buy	$59→$58
Aug 13, 2026	Argus Research	Bill Selesky	PT Raise	Buy	$50→$54
Aug 10, 2026	Evercore ISI Group	Chris McNally	PT Raise	Outperform	$60→$65
Aug 5, 2026	TD Cowen	Itay Michaeli	PT Raise	Buy	$49→$58
Aug 5, 2026	RBC Capital	Tom Narayan	Upgrade	Sector Perform→Outperform	$41→$52
Aug 5, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$48→$56
Jul 20, 2026	Goldman Sachs	Mark Delaney	Initiate	Buy	$48
Jul 13, 2026	RBC Capital	Tom Narayan	PT Raise	Sector Perform	$34→$41
Jul 9, 2026	UBS	Joseph Spak	PT Cut	Buy	$58→$55
Jul 8, 2026	Deutsche Bank	Edison Yu	Upgrade	Hold→Buy	$50
Jun 25, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$42→$48
Jun 5, 2026	UBS	Joseph Spak	PT Raise	Buy	$49→$58
May 6, 2026	UBS	Joseph Spak	PT Raise	Buy	$43→$49
May 6, 2026	TD Cowen	Itay Michaeli	PT Raise	Buy	$47→$49
May 6, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$35→$42
Apr 28, 2026	Deutsche Bank	Edison Yu	Initiate	Hold	$35
Apr 14, 2026	UBS	Joseph Spak	Initiate	Buy	$43
Apr 6, 2026	Wells Fargo	Colin Langan	Initiate	Overweight	$35

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on Versigent, Raises Price Target to $53

RBC Capital analyst Tom Narayan maintains Versigent (NYSE:VGNT) with a Outperform and raises the price target from $52 to $53.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Buy on Versigent, Lowers Price Target to $58

Goldman Sachs analyst Mark Delaney maintains Versigent (NYSE:VGNT) with a Buy and lowers the price target from $59 to $58.

Benzinga Newsdesk

PRO
Argus Research Maintains Buy on Versigent, Raises Price Target to $54

Argus Research analyst Bill Selesky maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $50 to $54.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Versigent, Raises Price Target to $65

Evercore ISI Group analyst Chris McNally maintains Versigent (NYSE:VGNT) with a Outperform and raises the price target from $60 to $65.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Versigent, Raises Price Target to $58

TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $49 to $58.

Benzinga Newsdesk

PRO
RBC Capital Upgrades Versigent to Outperform, Raises Price Target to $52

RBC Capital analyst Tom Narayan upgrades Versigent (NYSE:VGNT) from Sector Perform to Outperform and raises the price target from $41 to $52.

Benzinga Newsdesk